Search Results - "Klabe, R M"
-
1
Inhibition of Clinically Relevant Mutant Variants of HIV-1 by Quinazolinone Non-Nucleoside Reverse Transcriptase Inhibitors
Published in Journal of medicinal chemistry (18-05-2000)“…A series of 4-alkenyl and 4-alkynyl-3,4-dihydro-4-(trifluoromethyl)-2-(1H)-quinazolinones were found to be potent non-nucleoside reverse transcriptase…”
Get full text
Journal Article -
2
Expanded-Spectrum Nonnucleoside Reverse Transcriptase Inhibitors Inhibit Clinically Relevant Mutant Variants of Human Immunodeficiency Virus Type 1
Published in Antimicrobial Agents and Chemotherapy (01-12-1999)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
3
Synthesis and evaluation of quinoxalinones as HIV-1 reverse transcriptase inhibitors
Published in Bioorganic & medicinal chemistry letters (07-08-2000)“…A series of 3,3-disubstituted quinoxalinones was prepared and evaluated as HIV-1 reverse transcriptase inhibitors. The N-allyl ( 6b and 6f),…”
Get full text
Journal Article -
4
Synthesis and evaluation of benzoxazinones as HIV-1 reverse transcriptase inhibitors. Analogs of Efavirenz (SUSTIVA TM)
Published in Bioorganic & medicinal chemistry letters (15-11-1999)“…Two series of benzoxazinones differing in the aromatic substitution pattern were prepared and evaluated as HIV-1 reverse transcriptase inhibitors. The 5-fluoro…”
Get full text
Journal Article -
5
Synthesis and evaluation of analogs of Efavirenz (SUSTIVA TM) as HIV-1 reverse transcriptase inhibitors
Published in Bioorganic & medicinal chemistry letters (04-10-1999)“…Efavirenz (SUSTIVA TM) is a potent non-nucleoside reverse transcriptase inhibitor. Due to the observation of breakthrough mutations of the reverse…”
Get full text
Journal Article -
6
Thermodynamic linkage between the binding of protons and inhibitors to HIV-1 protease
Published in Protein science (01-01-1999)“…The aspartyl dyad of free HIV-1 protease has apparent pKas of ∼3 and ∼6, but recent NMR studies indicate that the aspartyl dyad is fixed in the doubly…”
Get full text
Journal Article -
7
Unsymmetrical cyclic ureas as HIV-1 protease inhibitors: Novel biaryl indazoles as P2/P2′ substituents
Published in Bioorganic & medicinal chemistry letters (15-11-1999)“…The preparation of unsymmetrical cyclic ureas bearing novel biaryl indazoles as P2/P2′ substituents was undertaken, utilizing a Suzuki coupling reaction as the…”
Get full text
Journal Article -
8
Preparation and Structure−Activity Relationship of Novel P1/P1‘-Substituted Cyclic Urea-Based Human Immunodeficiency Virus Type-1 Protease Inhibitors
Published in Journal of medicinal chemistry (24-05-1996)“…A series of novel P1/P1‘-substituted cyclic urea-based HIV-1 protease inhibitors was prepared. Three different synthetic schemes were used to assemble these…”
Get full text
Journal Article -
9
Potency and selectivity of inhibition of human immunodeficiency virus protease by a small nonpeptide cyclic urea, DMP 323
Published in Antimicrobial Agents and Chemotherapy (01-07-1994)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
10
Stereoisomers of Cyclic Urea HIV-1 Protease Inhibitors: Synthesis and Binding Affinities
Published in Journal of medicinal chemistry (03-12-1998)“…We have synthesized stereoisomers of cyclic urea HIV-1 protease inhibitors to study the effect of varying configurations on binding affinities. Four different…”
Get full text
Journal Article -
11
Design, Synthesis, and Evaluation of Tetrahydropyrimidinones as an Example of a General Approach to Nonpeptide HIV Protease Inhibitors
Published in Journal of medicinal chemistry (23-05-1997)“…Re-examination of the design of the cyclic urea class of HIV protease (HIVPR) inhibitors suggests a general approach to designing novel nonpeptide cyclic HIVPR…”
Get full text
Journal Article -
12
Nonsymmetric P2/P2‘ Cyclic Urea HIV Protease Inhibitors. Structure−Activity Relationship, Bioavailability, and Resistance Profile of Monoindazole-Substituted P2 Analogues
Published in Journal of medicinal chemistry (18-06-1998)“…Using the structural information gathered from the X-ray structures of various cyclic urea/HIVPR complexes, we designed and synthesized many nonsymmetrical…”
Get full text
Journal Article -
13
Potent cyclic urea HIV protease inhibitors with 3-aminoindazole P2/P2′ groups
Published in Bioorganic & medicinal chemistry letters (07-04-1998)“…Cyclic ureas containing 3-aminoindazole P2/P2′ groups are extremely potent inhibitors of HIV protease. The parent 3-aminoindazole 6 showed a K i × 0.01 nM but…”
Get full text
Journal Article -
14
Novel 2,2-dioxide-4,4-disubstituted-1,3-H-2,1,3-benzothiadiazines as non-nucleoside reverse transcriptase inhibitors
Published in Bioorganic & medicinal chemistry letters (17-01-2000)“…Benzothiadiazine non-nucleoside reverse transcriptase inhibitors (NNRTIs) of HIV have been synthesized via a novel process to afford active inhibitors, with…”
Get full text
Journal Article -
15
The synthesis and evaluation of cyclic ureas as HIV protease inhibitors: Modifications of the P1/P1′ residues
Published in Bioorganic & medicinal chemistry letters (07-04-1998)“…Two series of cyclic ureas modified at the P1/P1′ residue were prepared and evaluated for HIV protease inhibition and whole cell antiviral activity. Compounds…”
Get full text
Journal Article -
16
Does a diol cyclic urea inhibitor of HIV-1 protease bind tighter than its corresponding alcohol form? A study by free energy perturbation and continuum electrostatics calculations
Published in Journal of computer-aided molecular design (01-02-2001)“…The cyclic urea inhibitors of HIV-1 protease generally have two hydroxyl groups on the seven-membered ring. In this study, free energy perturbation and…”
Get full text
Journal Article -
17
Increased antiviral activity of cyclic urea HIV protease inhibitors by modifying the P1/P1′ substituents
Published in Bioorganic & medicinal chemistry letters (02-08-1999)“…A series of alkyl substituted P1/P1′ analogs was prepared in an attempt to increase translation of the 3-aminoindazole class of HIV protease inhibitors…”
Get full text
Journal Article -
18
The synthesis of symmetrical and unsymmetrical P1/P1′ cyclic ureas as HIV protease inhibitors
Published in Bioorganic & medicinal chemistry letters (05-05-1998)“…Cyclic urea SD146, a potent HIV protease inhibitor bearing a flat resistance profile, possessed poor solubility and bioavailability, which precluded further…”
Get full text
Journal Article -
19
Improved P1/P1‘ Substituents for Cyclic Urea Based HIV-1 Protease Inhibitors: Synthesis, Structure−Activity Relationship, and X-ray Crystal Structure Analysis
Published in Journal of medicinal chemistry (09-05-1997)“…We present several novel P1/P1‘ substituents that can replace the characteristic benzyl P1/P1‘ moiety of the cyclic urea based HIV protease inhibitor series…”
Get full text
Journal Article -
20
Synthesis and evaluation of novel quinolinones as HIV-1 reverse transcriptase inhibitors
Published in Bioorganic & medicinal chemistry letters (23-07-2001)“…A series of 4,4-disubstituted quinolinones was prepared and evaluated as HIV-1 reverse transcriptase inhibitors. The C-3 substituted compound 9h displayed…”
Get full text
Journal Article